Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Hepatitis C × Sofosbuvir × Clear all

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Non-Hodgkin 1 Liver Neoplasms 1 Liver Diseases 1 Hepatitis C 1

Interventions

Ribavirin 3 tremelimumab 1 telaprevir 1 peginterferon alfa-2a 1 menatetrenone 1 ledipasvir, sofosbuvir drug combination 1 Sofosbuvir 1 Infliximab 1 Hypothermia, Induced 1 Chromatography, High Pressure Liquid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02717949 2019-01-08

Optimal

University of Texas Southwestern Medical Center

Phase 4 Terminated

Hepatitis C, Liver Diseases, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡